Morgan Stanley upgraded Bunge (BG) to Overweight from Equal Weight with a price target of $120, up from $95. The firm says synergy optionality creates a favorable risk/reward in shares of Bunge. The Viterra synergies will likely surprise positively, the analyst tells investors in a research note.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BG: